Skip to main content

Today's Cannabis Economic News (2026-07-03 JST)

News SummaryThis article summarizes the key points by organizing the updates from multiple sources.
Published 2026.07.03Updated 2026.07.03 05:38
Today's Cannabis Economic News (2026-07-03 JST)

There have been a series of developments in regulations, businesses, capital markets, and research. To make the economic impact easier to understand, we will organize the information primarily using quantitative data.


概況

In the United States, the Department of Justice (DOJ) and the DEA are accelerating their efforts regarding federal-level rescheduling (reclassification to Schedule III), while opposition lawsuits are also ongoing. Peripheral regulations such as online advertising restrictions and revisions to state laws could also impact the industry's cost structure. Meanwhile, in Europe, a single-site facility dedicated to plant health is preparing to begin operations on Jersey Island, which is expected to improve productivity and the efficiency of genetic asset management. Investor sentiment is diversifying across individual stocks and related industries (ansarri), and in the research field, the "entourage effect" is becoming more refined.CBDResearch into the mechanisms of pain and psychiatric symptoms is progressing.


By topic

Regulation and Judiciary

ThemeQuantitative information/key pointsEconomic outlook
DOJ refutes request to block reschedulingOpponents argue the Justice Department has "pocketbook interests" in keeping marijuana on Schedule I. The DC Circuit Court of Appeals is currently consolidating three lawsuits.The drug testing industry and some pharmaceutical companies face a risk of restructuring their revenue models. If reclassification progresses, it could lead to lower R&D and tax costs, potentially resulting in a reallocation of investments across the industry equivalent to a full cycle of equipment upgrades.
DEA ALJ hearing beginsThe process began on June 29th. The DEA and the seven invited officials delivered opening statements. Although there were concerns beforehand that the process would be biased towards the opposition, the initial stages emphasized that the process would be based on scientific evidence.As scientific evidence is verified, there is room to reduce the cost of regulatory uncertainty (the "invisible tax" on compliance and legal matters).
The House of Representatives passes the KIDS bill.The bill passed with 267 votes in favor and 117 against. It clarifies the platform's obligation to protect minors from advertisements for marijuana, tobacco, gambling, and alcohol.Digital advertising reach efficiency is declining, increasing the risk of higher cost per acquisition (CPA). The number of votes in favor is equivalent to "a vote difference larger than the total number of players in all 12 professional baseball teams," making it a highly anticipated move in the Senate.
Rhode Island requests license reactivation with elimination of residency requirementThe in-state residency requirement for majority ownership under the 2022 law has been removed. Existing applications have been invalidated, and the new process has been restarted. In-state references have been removed from six social equity slots.The expansion of the pool of businesses is expected to intensify bidding competition and reduce the "auction premium" on license acquisition costs.
Illinois to double the amount of drugs allowed for adults.The adult possession limit will be doubled. Regulations on hemp-derived THC products will be strengthened, and licensing rules will also be revised.The accelerated transition to the legitimate market is a factor boosting sales. However, the price advantage of the gray market is expected to shrink due to THC regulations on hemp.
Supreme Court gives majority support to legalize gun ownership for marijuana users.Public opinion shows 55% support and 26% opposition. Republicans support it 58%, Democrats 52%, and independents 56%.The reduction in stigma has also had an impact on how local governments set levies and fees, contributing to a softening of the barriers to starting a business.

reference:(Marijuana Moment: DOJ Petition), (Business of Cannabis: DEA Hearing), (Marijuana Moment: KIDS bill), (Marijuana Moment: Rhode Island), (Marijuana Moment: Illinois), (Marijuana Moment: Public Opinion Polls)


The figures for regulations and public opinion share a common statistical concept: "how much support is dominant." A 55% approval rating in a sample (public opinion poll) from a population (the entire nation) is a more clearly biased signal than a coin toss. The technical term "scheduling" refers to a system that classifies drugs by their harmfulness and medical use; the lower the classification, the potentially lower the barriers to research and commercial distribution.

Enterprise/Supply Chain

Company動 きImpact on supply/cost
Northern Leaf × 3R BiotechJersey has introduced Europe's first "single-site" plant health facility, spanning 10 square feet. This facility accounts for approximately 90% of the island's medical cannabis exports and saw a 25% increase in production capacity last year.Reduced losses through on-site preservation and regeneration of genetic assets. Consolidated fragmentation costs from outsourcing, leading to expected stable shipments. Scale advantages are ensured with an area equivalent to "dozens of school gymnasiums."
Medical cannabis companies (2 companies, anonymous)An intervention request has been filed in a lawsuit opposing rescheduling, alleging "economic, regulatory, and business damages."Depending on the ruling, the conditions for research tax incentives, logistics insurance, and access to finance could diverge. Legal costs could be equivalent to those for opening one to several new stores.

reference:(Business of Cannabis: Northern Leaf), (Marijuana Moment: Corporate Intervention)


Market/Investment

Itemquantitative informationSuggestion
Attention on Ansalary stockGRWG, HYFM, and SMG are among the stocks to watch in July. All are "contactless" type companies (equipment, horticulture, and hydroponics).Due to the relatively low regulatory risk, funds tend to remain defensively even under the uncertainty of rescheduling.
Roadmap for the Revival of European Textile HempA strategy for 2035 involving the V4 countries (Czech Republic, Hungary, Poland, Slovakia) plus a German partner. It focuses on premium, traceable fibers, rather than competing with low-cost Asian markets.Investment in processing infrastructure and coordination of supply chains are key. Strengthening EU sustainability standards will allow for price premiums.
Weekly trends of stocks related to the Dutch marketCronos Group, High Tide, and Village Farms rose 27% in a week, according to local media.There are also speculations linked to European news (data protection, supply infrastructure).

reference:(Marijuana Stocks: Stocks to Watch), (HempToday: 2035 Roadmap), (cannabisindustrie.nl: Week 27)


Security Compliance

Casequantitative informationBusiness Impact
Spanish club member data leakApproximately 985,000 IDs (passports, driver's licenses, etc.) were publicly exposed. It was reported that 5,000 IDs were uploaded daily from the app.Increased costs for additional KYC/AML and privacy measures, along with "reviews on cyber insurance" and "rising customer churn rates," are putting pressure on short-term profits.

reference:(cannabisindustrie.nl: Data breach)


"KYC (Know Your Customer)" is a system that thoroughly verifies the identity of individuals to prevent impersonation and money laundering. Clubs and retailers need to minimize the handling of IDs and implement encryption and strict access control to avoid losing the trust of their members and customers.

Research/Clinical

ThemeMain findingsPractical implications
Refinement of the entourage effectThe interaction varies depending on the type of terpene and the target receptor. In CB1 receptors, borneol, limonene, sabinene, terpineol, α-pinene, and ocimene synergistically enhance the THC reaction. In CB2 receptors, β-caryophyllene and linalool synergistically enhance the THC reaction.This can be used in product design to improve the reproducibility of effects through "terpene optimization by receptor" and in inventory management strategies based on "efficacy-based SKUs".
CBDand the mechanisms of pain and emotionCBD administration to the anterior insular cortex (AIC) of rats reduced neuropathic pain and anxiety/depressive-like behaviors. This suggests involvement of CB1 and 5-HT1A receptors. The dosage was 15/30/60 nmol.The combination of CB1 and the serotonin pathway is useful for organizing the mechanism of action of future pain management products.
THC/CBD in RLS (Restless Legs Syndrome)A 3-month open-label trial of 2.7 mg THC/2.5 mg CBD. 18 participants (16 of whom had multiple sclerosis). The primary endpoint was improvement in IRLS score.Potential improvement in sleep-related quality of life. Attention should be paid to dosage design, safety, and regulatory considerations.

reference:(Marijuana Moment: Entourage), (PubMed: CBD and AIC), (PubMed: THC/CBD for RLS)


The "CB1/CB2" mentioned in research refers to the names of switches (receptors) in the body. Knowing which terpenes are most effective on which switches makes it easier to stabilize the effects of the same amount of THC.

Background information you should know (perspectives from prominent US media outlets and experts)

  • Marijuana Moment repeatedly points out that litigation surrounding rescheduling directly impacts the industry's "practical costs" (tax, financial, and research). The actions of the DOJ and DEA have repercussions not only on the stock market but also on the cash flow of small and medium-sized businesses.
  • Business of Cannabis reports that the DEA hearing is proceeding in a way that is "science-based," contrary to concerns. This could lead to increased transparency in regulatory design and a reduction in investors' risk premiums.
  • European company HempToday suggests that textile hemp should compete on "sustainability and traceability" rather than "low price." Coordinated investment in the supply chain is essential.

reference:(Marijuana Moment), (Business of Cannabis), (HempToday)


Today's highlights (3 points)

  1. We should prepare for a two-front regulatory battle. Federal-level measures (reclassification and the KIDS Act) and state-level measures (elimination of RI requirements, doubling of IL possession limits, and hemp THC regulations) will proceed simultaneously, requiring simultaneous optimization of advertising, legal, and inventory strategies.
  2. "Single-site" supply chain management improves yield and speed. The Jersey example shows that in-house inspection, cleaning, storage, and propagation can lead to a substantial increase in inventory turnover.
  3. Research advancements directly impact product design. The idea of ​​optimizing terpenes for each receptor differentiates products not by price, but by "consistency of effect," contributing to increased repeat purchase rates and maximizing customer lifetime value (LTV).

Collection List

Share this article

    RANKING

    Choose from popular products

    Top of page